Back to Authors

Janardhanan, Rajiv

https://orcid.org/0000-0002-3904-3900

Mayo Clinic

Mayo Clinic

Citations 1

Effect of Hyperglycemia on Human Monocyte Activation
Nandy, Debashis, Janardhanan, Rajiv , Basu, Ananda , Mukhopadhyay, Debabrata

Journal of Investigative Medicine | May 11, 2016 | Volume: 59 | Issue: 4 | Pages: 661-667

10.2310/jim.0b013e31820ee432 Get It

Our recent study defined the chemokine-induced human monocyte signaling under normoglycemic condition. To explore the hyperglycemia-induced monocyte signaling, we performed adhesion, migration, and transmigration assays on human monocytes obtained from THP-1 cell line in the presence of normal (5 mM) and high (10 and 20 mM) glucose concentrations without chemokines. We observed augmented ( P < 0.01) monocyte adhesion to human umbilical vein endothelial cell monolayer at 10 than 5 mM glucose with no further increase at 20-mM glucose concentration ( P < 0.07 vs 10 mM; P < 0.01 vs 5 mM). But incremental increases in monocyte migration ( P < 0.01), transmigration ( P < 0.01), and stress fiber response ( P < 0.01) were observed at 10- and 20-mM glucose concentrations in comparison to 5-mM glucose concentrations. We found gradational increase ( P < 0.01) in phosphorylation of Akt S473 and glycogen synthase kinase (GSK3β S9 ) in hyperglycemia (10 and 20 mM) when compared with 5 mM glucose. Furthermore, hyperglycemia (both 10 and 20 mM)-treated monocyte showed up-regulated phosphorylation of p101 and p110γ subunits of PI-3 kinase in comparison to 5 mM glucose. Hyperglycemia-induced monocyte migration was restored to basal levels in the presence of PI-3 kinase inhibitor, LY. These observations imply that modest hyperglycemia per se, as is commonly observed in diabetic individuals, is a potent stimulator of monocyte activity even without chemokines.